Pro-gastrin-releasing peptide (ProGRP)?Sensitive marker and prognostic factor in patients with small cell lung cancer
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F12%3A00060612" target="_blank" >RIV/00216224:14110/12:00060612 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1016/j.lungcan.2012.05.079" target="_blank" >http://dx.doi.org/10.1016/j.lungcan.2012.05.079</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.lungcan.2012.05.079" target="_blank" >10.1016/j.lungcan.2012.05.079</a>
Alternative languages
Result language
angličtina
Original language name
Pro-gastrin-releasing peptide (ProGRP)?Sensitive marker and prognostic factor in patients with small cell lung cancer
Original language description
Progastrin-releasing peptide (ProGRP) is a relatively stable precursor of the gastrin releasing peptid. Studies suggest that the levels of ProGRP in blood play an important role in the diagnosis and treatment of small cell lung cancer (SCLC) patients. Neuron specific enolase (NSE) is also a useful marker for detection of SCLC. NSE was seen as a predictor of survival independently of other prognostic factors. The relevance of serum NSE as a tumor marker for SCLC has been demonstrated in several investigations.
Czech name
—
Czech description
—
Classification
Type
O - Miscellaneous
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2012
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů